|
|||||||
|
Advertisement 
|
BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View) BioTime, Inc., an Alameda-based biotechnology company, announced today that it has signed a deal with Geron Corporation to acquire intellectual property and other assets related to human embryonic stem cell programs […] BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View) Alameda biotech firm BioTime announced late yesterday that it is making progress on its efforts to acquire stem cell research and development assets from Geron Corporation of Menlo Park. […] BioTime of Alameda has made a bid for stem cell research assets owned by Geron Corporation. Alameda’s BioTime has issued an open letter to shareholders of Geron Corporation, encouraging them to support a $53 million deal that would see a BioTime subsidiary acquire stem cell research and development assets from Geron. […] |
 |
|||||
|
Copyright © - All Rights Reserved Action Alameda News Letters to the Editor Powered by WordPress & Atahualpa |
|||||||
Twitter Feed
Recent Comments